Prilenia
Biopharmaceuticals
2 open rolesBiopharmaceuticalsNaarden, Netherlands58 employees$144M raisedEst. 2018
Forbion
Morningside
Sands Capital
SV Health Investors
Sectoral Asset Management
Talisman
About Prilenia
- Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.
- It is dedicated to improving the lives of patients and their families by developing treatments for conditions like Huntington's disease and ALS.
Prilenia is listed on Rocketlist with 2 active roles. The company is categorized as Biopharmaceuticals in BioTech. Prilenia is at Series B stage, with a B2B business model, headquartered in Naarden, Netherlands. Prilenia was founded in 2018 and has 58 employees. Prilenia has raised $144M. Active roles are refreshed daily from public hiring sources.